JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$3.58B |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$2.7B |
| 3 |
Apple
AAPL
|
+$1.71B |
| 4 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.57B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.51B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$920M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$817M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.23% |
| 2 | Technology | 15.68% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Healthcare | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4526
Axogen
AXGN
$2.34B
| $496K | ﹤0.01% |
22,991
-35,213
| -60% | -$712K |
2017 Q4
14 quarters
|
|
|
TRUE
4527
DELISTED
TrueCar
TRUE
| $495K | ﹤0.01% |
87,607
-242
| -0.3% | -$1.22K |
2016 Q4
18 quarters
|
|
4528
Western New England Bancorp
WNEB
$274M
| $495K | ﹤0.01% |
60,732
-93,540
| -61% | -$773K |
2017 Q4
14 quarters
|
|
|
BRG
4529
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $495K | ﹤0.01% |
48,709
-28,068
| -37% | -$272K |
2015 Q2
24 quarters
|
|
4530
First Bancorp
FNLC
$380M
| $493K | ﹤0.01% |
16,735
-16,897
| -50% | -$505K |
2017 Q4
14 quarters
|
|
4531
Vaxcyte
PCVX
$8.34B
| $493K | ﹤0.01% |
21,881
-43,064
| -66% | -$882K |
2020 Q3
3 quarters
|
|
4532
Tiptree Inc
TIPT
$644M
| $493K | ﹤0.01% |
52,994
-22,611
| -30% | -$239K |
2017 Q4
14 quarters
|
|
|
FOXO
4533
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
| $490K | ﹤0.01% |
251
| – | – |
2021 Q1
1 quarter
|
|
4534
Verrica Pharmaceuticals
VRCA
$82.4M
| $490K | ﹤0.01% |
4,334
+1,560
| +56% | +$189K |
2018 Q3
11 quarters
|
|
4535
First Trust Water ETF
FIW
$1.72B
| $489K | ﹤0.01% |
5,850
+1,250
| +27% | +$103K |
2017 Q3
15 quarters
|
|
|
LHAA
4536
DELISTED
Lerer Hippeau Acquisition Corp. Class A Common Stock
LHAA
| $488K | ﹤0.01% |
49,500
| – | – |
2021 Q1
1 quarter
|
|
|
RESN
4537
DELISTED
Resonant Inc.
RESN
| $488K | ﹤0.01% |
152,136
-64,563
| -30% | -$222K |
2020 Q2
4 quarters
|
|
4538
Invesco S&P 500 Quality ETF
SPHQ
$18.8B
| $486K | ﹤0.01% |
10,000
-400
| -4% | -$18.6K |
2021 Q1
1 quarter
|
|
4539
Acacia Research
ACTG
$425M
| $485K | ﹤0.01% |
71,718
-92,726
| -56% | -$552K |
2015 Q4
22 quarters
|
|
|
AGS
4540
DELISTED
PlayAGS
AGS
| $485K | ﹤0.01% |
49,032
-29,810
| -38% | -$275K |
2018 Q1
13 quarters
|
|
4541
Envoy Medical
COCH
$51.1M
| $485K | ﹤0.01% |
+49,998
| New | +$486K |
2021 Q2
0 quarters
|
|
|
ACHL
4542
DELISTED
Achilles Therapeutics
ACHL
| $484K | ﹤0.01% |
49,405
-576,345
| -92% | -$7.81M |
2021 Q1
1 quarter
|
|
|
MCW
4543
DELISTED
Mister Car Wash
MCW
| $481K | ﹤0.01% |
+22,333
| New | +$475K |
2021 Q2
0 quarters
|
|
4544
FRP Holdings
FRPH
$393M
| $478K | ﹤0.01% |
17,156
-19,108
| -53% | -$529K |
2017 Q4
14 quarters
|
|
|
SNCR
4545
DELISTED
Synchronoss Technologies
SNCR
| $478K | ﹤0.01% |
14,824
-222,122
| -94% | -$6.25M |
2018 Q4
10 quarters
|
|
|
FMTX
4546
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $478K | ﹤0.01% |
19,207
+3,389
| +21% | +$91.1K |
2020 Q3
3 quarters
|
|
|
DZSI
4547
DELISTED
DZS Inc. Common Stock
DZSI
| $477K | ﹤0.01% |
23,012
-19,920
| -46% | -$346K |
2016 Q4
18 quarters
|
|
|
ESTE
4548
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $477K | ﹤0.01% |
43,081
-43,913
| -50% | -$399K |
2017 Q4
14 quarters
|
|
4549
Alta Equipment Group
ALTG
$206M
| $476K | ﹤0.01% |
35,870
-20,850
| -37% | -$285K |
2020 Q2
4 quarters
|
|
4550
First Trust Consumer Staples AlphaDEX Fund
FXG
$201M
| $476K | ﹤0.01% |
8,347
| – | – |
2013 Q2
32 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2021 Portfolio in Review
As of Q2 2021, JP Morgan Chase held 6,872 positions worth $838B, up 12% from $749B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase deployed $31.1B of net new capital in Q2 2021, opening 693 new positions and adding to 2,351 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $1.51B trimmed.
- JP Morgan Chase's largest Q2 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2021, an estimated $3.58B increase.
- JP Morgan Chase's biggest Q2 2021 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.51B.
- JP Morgan Chase fully exited INPHI CORPORATION in Q2 2021, selling an estimated $333M.
- JP Morgan Chase's ten largest holdings make up 16% of its $838B portfolio in Q2 2021.
- JP Morgan Chase opened 693 new positions and closed 449 in Q2 2021.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $838B.
Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.